Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Sunday, November 15, 2020

Intestinal and Extra-Intestinal Manifestations of Campylobacter in the Immunocompromised Host

Alexandros G.Sfakianakis shared this article with you from Inoreader

Abstract

Purpose of review

Describe most recent data on manifestations and treatment of intestinal and extra-intestinal manifestations of Campylobacter among immunocompromised patients.

Recent findings

Resistance to fluoroquinolones, macrolides, and tetracycline challenge traditional empiric therapies.

Summary

Recurrent Campylobacter enteritis and bacteremia are associated with hypogammaglobinemia, HIV, transplant-associated immunotherapy, and hematologic malignancies. C. jejuni and C. coli are the most commonly associated Campylobacter species although C. fetus, C. upsaliensis, C. lari, C. curvus, and C. rectus should be considered as potential causative agents of rare extra-intestinal infections. Successful diagnosis and treatment of these cases may require the recognition of the limits of standard diagnostics and the recent emergence of highly resistant strains of Campylobacter, particularly C. coli.

View on the web

No comments:

Post a Comment